Literature DB >> 20548284

Mammary epithelial transplant procedure.

Karen A Dunphy1, Luwei Tao, D Joseph Jerry.   

Abstract

This article describes and compares the fat pad clearance procedure developed by DeOme KB et al. and the sparing procedure developed by Brill B et al., followed by the mammary epithelial transplant procedure. The mammary transplant procedure is widely used by mammary biologists because it takes advantage of the fact that significant development of the mammary epithelium doesn't occur until after puberty. At 3 weeks of age, growth of the mammary epithelial tree is confined to the vicinity of the nipple and the fat pad is largely devoid of mammary epithelium, but by 7 weeks of age the epithelial ductal tree extends throughout the entire fat pad. Therefore, if this small portion of the fat pad containing epithelium, the region between the nipple and the lymph node, is removed at 3 weeks of age, the endogenous epithelium will never populate the mammary fat pad and the fat pad is described as "cleared". At this time, mammary epithelium from another source can be transplanted in the cleared fat pad where it has the potential to extend mammary ductal trees through out the fat pad. This procedure has been utilized in many experimental models including the examination of tumor phenotype in transgenic mammary epithelial tissue without the confounding effects of genotype on the entire animal, in the identification of mammary stem cells by transplanting cells in limited dilution, determining if hyperplastic nodules proceed to mammary tumors, and to assess the effect of prior hormone exposure on the behavior of the mammary epithelium. Three week old host mice are anesthetized, cleaned and restrained on a surgical stage. A mid-sagittal incision is made through the skin, but not the peritoneum, extending from the pubis to the sternum. Oblique cuts are made through the skin from the mid-sagittal incision across the pelvis toward each leg. The skin is pulled away from the peritoneum to expose the 4th inguinal mammary gland. The fat pad is cleared by removing the fat pad tissue anterior to the lymph node. Epithelium fragments or epithelial cells are transplanted into the remaining cleared fat pad and the mouse is closed.

Entities:  

Mesh:

Year:  2010        PMID: 20548284      PMCID: PMC3153903          DOI: 10.3791/1849

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  8 in total

1.  Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice.

Authors:  K B DEOME; L J FAULKIN; H A BERN; P B BLAIR
Journal:  Cancer Res       Date:  1959-06       Impact factor: 12.701

2.  Generation of a functional mammary gland from a single stem cell.

Authors:  Mark Shackleton; François Vaillant; Kaylene J Simpson; John Stingl; Gordon K Smyth; Marie-Liesse Asselin-Labat; Li Wu; Geoffrey J Lindeman; Jane E Visvader
Journal:  Nature       Date:  2006-01-05       Impact factor: 49.962

3.  Purification and unique properties of mammary epithelial stem cells.

Authors:  John Stingl; Peter Eirew; Ian Ricketson; Mark Shackleton; François Vaillant; David Choi; Haiyan I Li; Connie J Eaves
Journal:  Nature       Date:  2006-01-04       Impact factor: 49.962

4.  Preneoplastic lesions in murine mammary cancer.

Authors:  D Medina
Journal:  Cancer Res       Date:  1976-07       Impact factor: 12.701

5.  A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development.

Authors:  D J Jerry; F S Kittrell; C Kuperwasser; R Laucirica; E S Dickinson; P J Bonilla; J S Butel; D Medina
Journal:  Oncogene       Date:  2000-02-21       Impact factor: 9.867

6.  A sparing procedure to clear the mouse mammary fat pad of epithelial components for transplantation analysis.

Authors:  B Brill; N Boecher; B Groner; C S Shemanko
Journal:  Lab Anim       Date:  2008-01       Impact factor: 2.471

7.  An adjunct mammary epithelial cell population in parous females: its role in functional adaptation and tissue renewal.

Authors:  Kay-Uwe Wagner; Corinne A Boulanger; MaLinda D Henry; Magdalene Sgagias; Lothar Hennighausen; Gilbert H Smith
Journal:  Development       Date:  2002-03       Impact factor: 6.868

8.  Estrogen and progesterone induce persistent increases in p53-dependent apoptosis and suppress mammary tumors in BALB/c-Trp53+/- mice.

Authors:  Karen A Dunphy; Anneke C Blackburn; Haoheng Yan; Lauren R O'Connell; D Joseph Jerry
Journal:  Breast Cancer Res       Date:  2008-05-12       Impact factor: 6.466

  8 in total
  11 in total

1.  Attenuation of Mammary Gland Dysplasia and Feeding Difficulties in Tabby Mice by Fetal Therapy.

Authors:  Mandy Wahlbuhl; Sonia Schuepbach-Mallepell; Christine Kowalczyk-Quintas; Angela Dick; Fabian B Fahlbusch; Pascal Schneider; Holm Schneider
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-06-01       Impact factor: 2.673

2.  Orthotopic Implantation Achieves Better Engraftment and Faster Growth Than Subcutaneous Implantation in Breast Cancer Patient-Derived Xenografts.

Authors:  Maiko Okano; Masanori Oshi; Ali Butash; Ichiro Okano; Katsuharu Saito; Tsutomu Kawaguchi; Masayuki Nagahashi; Koji Kono; Toru Ohtake; Kazuaki Takabe
Journal:  J Mammary Gland Biol Neoplasia       Date:  2020-02-27       Impact factor: 2.673

3.  Human Breast Cancer Xenograft Model Implicates Peroxisome Proliferator-activated Receptor Signaling as Driver of Cancer-induced Muscle Fatigue.

Authors:  Hannah E Wilson; Kacey K Rhodes; Daniel Rodriguez; Ikttesh Chahal; David A Stanton; Joseph Bohlen; Mary Davis; Aniello M Infante; Hannah Hazard-Jenkins; David J Klinke; Elena N Pugacheva; Emidio E Pistilli
Journal:  Clin Cancer Res       Date:  2018-12-17       Impact factor: 12.531

4.  Electrophilic fatty acids impair RAD51 function and potentiate the effects of DNA-damaging agents on growth of triple-negative breast cells.

Authors:  Alparslan Asan; John J Skoko; Chen-Shan Chen Woodcock; Bentley M Wingert; Steven R Woodcock; Daniel Normolle; Yi Huang; Jeremy M Stark; Carlos J Camacho; Bruce A Freeman; Carola A Neumann
Journal:  J Biol Chem       Date:  2018-11-26       Impact factor: 5.157

5.  Epigenome modulated xenobiotic detoxification pathways control DMBA-induced breast cancer in agouti Avy/a mice.

Authors:  Simbarashe Mazambani; Madeleine Morris; Venugopalan Cheriyath
Journal:  Epigenetics       Date:  2019-05-09       Impact factor: 4.528

6.  Epithelial Xbp1 is required for cellular proliferation and differentiation during mammary gland development.

Authors:  Daisuke Hasegawa; Veronica Calvo; Alvaro Avivar-Valderas; Abigale Lade; Hsin-I Chou; Youngmin A Lee; Eduardo F Farias; Julio A Aguirre-Ghiso; Scott L Friedman
Journal:  Mol Cell Biol       Date:  2015-02-23       Impact factor: 4.272

7.  Aberrant activation of NF-κB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ.

Authors:  Whitney Barham; Lianyi Chen; Oleg Tikhomirov; Halina Onishko; Linda Gleaves; Thomas P Stricker; Timothy S Blackwell; Fiona E Yull
Journal:  BMC Cancer       Date:  2015-09-30       Impact factor: 4.430

8.  Oncogenic transformation of mammary epithelial cells by transforming growth factor beta independent of mammary stem cell regulation.

Authors:  Karen A Dunphy; Jae-Hong Seo; Daniel J Kim; Amy L Roberts; Luwei Tao; James DiRenzo; Amanda L Balboni; Giovanna M Crisi; Mary J Hagen; Thiruppavai Chandrasekaran; Kelly J Gauger; Sallie Smith Schneider; D Joseph Jerry
Journal:  Cancer Cell Int       Date:  2013-07-25       Impact factor: 5.722

9.  The invadopodia scaffold protein Tks5 is required for the growth of human breast cancer cells in vitro and in vivo.

Authors:  Barbara Blouw; Manishha Patel; Shinji Iizuka; Christopher Abdullah; Weon Kyoo You; Xiayu Huang; Jian-Liang Li; Begoña Diaz; William B Stallcup; Sara A Courtneidge
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.240

10.  Quantitation of TGF-β proteins in mouse tissues shows reciprocal changes in TGF-β1 and TGF-β3 in normal vs neoplastic mammary epithelium.

Authors:  Kathleen C Flanders; Yu-An Yang; Michelle Herrmann; JinQiu Chen; Nerissa Mendoza; Amer M Mirza; Lalage M Wakefield
Journal:  Oncotarget       Date:  2016-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.